Compare TFII & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFII | RGEN |
|---|---|---|
| Founded | 1957 | 1981 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | TFII | RGEN |
|---|---|---|
| Price | $99.63 | $162.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 10 |
| Target Price | $112.20 | ★ $170.90 |
| AVG Volume (30 Days) | 271.4K | ★ 797.9K |
| Earning Date | 10-30-2025 | 10-28-2025 |
| Dividend Yield | ★ 1.84% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.89 | 0.03 |
| Revenue | ★ $8,047,566,000.00 | $707,890,000.00 |
| Revenue This Year | N/A | $17.84 |
| Revenue Next Year | $2.77 | $12.57 |
| P/E Ratio | ★ $25.36 | $6,320.44 |
| Revenue Growth | N/A | ★ 11.74 |
| 52 Week Low | $72.02 | $102.97 |
| 52 Week High | $155.12 | $182.52 |
| Indicator | TFII | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 69.01 | 52.39 |
| Support Level | $86.94 | $160.11 |
| Resistance Level | $100.40 | $170.40 |
| Average True Range (ATR) | 2.64 | 5.46 |
| MACD | 1.75 | -0.76 |
| Stochastic Oscillator | 91.71 | 44.17 |
TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customers' specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.